Have you or your loved ones been diagnosed with atrial fibrillation?

You may be eligible to participate in a atrial fibrillation clinical trial.

Have you or your loved ones been diagnosed with atrial fibrillation? You may be eligible to participate in a atrial fibrillation clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Atrial Fibrillation Clinical Trial in Geelong Victoria
NCT01522898 | Interventional

Have you or your loved ones been diagnosed with atrial fibrillation?

You may be eligible to participate in a atrial fibrillation clinical trial.

Have you or your loved ones been diagnosed with atrial fibrillation? You may be eligible to participate in a atrial fibrillation clinical trial.

Completed

Male & Female

18 Years +

This study has recruited 145 Participants

Cardiac resynchronization therapy (CRT) is a treatment for heart failure in patients who also suffer from ventricular dyssynchrony, a form of uncoordinated contraction of the ventricle (lower pumping chamber of the heart). In the past decade, CRT has become an established treatment for heart failure patients who are in normal rhythm, called sinus rhythm. An important subset of heart failure patients are those with atrial fibrillation (AF), who make up around 1 in 4 HF patients, and are over-represented amongst HF patients with more advanced symptoms. In heart failure patients with AF, CRT has proven not to be as effective as in sinus rhythm, due to competition between beats generated by the CRT device and beats conducted from the heart's own electrical conduction system. In the current study, we aim to test the hypothesis that ablating the AV node, which controls electrical conduction from the heart's atria (top chamber) to its ventricles (lower chambers), will improve survival and heart failure symptoms in CRT patients with co-existent AF. The results are important, because they will provide a way of passing on the benefits of CRT, such as improved survival, less heart failure symptoms, and better quality of life, to heart failure patients who also suffer from AF.